Patton Albertson Miller Group, LLC Amgen Inc Transaction History

Patton Albertson Miller Group, LLC

$720 Million
Q3 2024

A detailed history of Patton Albertson Miller Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Patton Albertson Miller Group, LLC holds 4,056 shares of AMGN stock, worth $1.07 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

4,056

Previous 4,056 -0.0%

Holding current value

$1.07 Million

Previous $1.27 Million 3.08%

% of portfolio

0.18%

Previous 0.18%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $3,153 - $3,831	-12 Reduced 0.29%	4,056 $1.27 Million
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $16,132 - $19,473	-60 Reduced 1.45%	4,068 $1.16 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $39,633 - $44,711	155 Added 3.9%	4,128 $1.19 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $169,453 - $210,381	775 Added 24.23%	3,973 $1.07 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $53,781 - $63,595	-251 Reduced 7.28%	3,198 $710,000
Q1 2023 Apr 21, 2023	SELL	$225.79 - $275.2 $3,386 - $4,128	-15 Reduced 0.43%	3,449 $833,000
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $32,064 - $40,741	-140 Reduced 3.88%	3,464 $0
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $33,444 - $37,719	-149 Reduced 3.97%	3,604 $812,000
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $31,145 - $34,659	-135 Reduced 3.47%	3,753 $913,000
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $13,156 - $14,554	-60 Reduced 1.52%	3,888 $940,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $15,910 - $18,208	-80 Reduced 1.99%	3,948 $888,000
Q3 2021 Oct 27, 2021	SELL	$212.27 - $248.7 $23,349 - $27,357	-110 Reduced 2.66%	4,028 $857,000
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $57,460 - $63,748	-246 Reduced 5.61%	4,138 $1.01 Million
Q1 2021 Apr 21, 2021	SELL	$221.91 - $258.6 $1,997 - $2,327	-9 Reduced 0.2%	4,384 $1.09 Million
Q4 2020 Feb 25, 2021	SELL	$216.38 - $257.67 $85,686 - $102,037	-396 Reduced 8.27%	4,393 $1.02 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $142,901 - $158,918	-609 Reduced 11.28%	4,789 $1.22 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $19,583 - $24,031	-99 Reduced 1.8%	5,398 $1.27 Million
Q1 2020 May 22, 2020	SELL	$182.24 - $241.7 $7,654 - $10,151	-42 Reduced 0.76%	5,497 $1.11 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $18,921 - $24,320	-100 Reduced 1.77%	5,539 $1.34 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $40,567 - $48,608	233 Added 4.31%	5,639 $1.09 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $554,110 - $649,542	3,324 Added 159.65%	5,406 $1.06 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $10,168 - $11,870	57 Added 2.81%	2,082 $387,000
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $6,777 - $7,920	40 Added 2.02%	2,025 $345,000
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $29,538 - $33,003	-175 Reduced 8.1%	1,985 $345,000
Q3 2017 Oct 06, 2017	BUY	$167.29 - $191.0 $361,346 - $412,560	2,160	2,160 $404,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Albertson Miller Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patton Albertson Miller Group, LLC with notifications on news.

Account

Patton Albertson Miller Group, LLC Amgen Inc Transaction History